STARTSEITE
Impressum
Datenschutz
  
 
  SPOT ON
 

Rebate contract = advertising contract: yellow card for DAK (health insurance)

 
  NEW ON THE MARKET
 

Ospemifene (SENSHIO) - oral treatment for vaginal atrophy Local treatment of vaginal atrophy with hormone-free and estrogen-containing preparations

 
  THERAPY FROM A CRITICAL VIEWPOINT
 

EMPA-REG-OUTCOME trial with empagliflozin: doubts about proper conduction reinforced

 
  BEWARE MISINFORMATION
 

Does ciclopirox (CILCOPOLI) convince against onychomycosis?

 
  IN BRIEF

LEADER trial with liraglutide (VICTOZA)

 
  CURRENT ADR NETWORK REPORT
 

Rapid weight gain with mirtazapine

 
  SIDE EFFECTS
 

Clarithromycin (KLACID, generics): neuropsychiatric adverse effects

Priapism with methylphenidate (e.g. RITALIN)

Aripiprazole (e.g. ABILIFY): impulse control disorders

 
  e a-t IN THE INTERNET
 

LEADER study with liraglutide (VICTOZA): first positive data for a GLP-1 agonist in type 2 diabetes (extended version)

 

© arznei-telegramm 7/2016